Odyssey Therapeutics, Inc. · NASDAQ:ODTX
Haas Jason bought 1,000 Odyssey Therapeutics, Inc. shares (Form 4)
Traded May 8, 2026 · Filed May 11, 2026
On May 8, 2026, Haas Jason (Chief Financial Officer) bought 1,000 Odyssey Therapeutics, Inc. shares at US$20.00 for US$20,000, leaving 62,908 shares. Filed May 11, 2026 (Form 4).
- Bought
- 1,000 shares
- Price
- US$20.00
- Value
- US$20,000
- Holding after
- 62,908 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 8, 2026 | Common Stock | Buy | 1,000 | US$20.00 | 62,908 | Direct |
Source
Related
- Odyssey Therapeutics, Inc.
- Haas Jason
- Odyssey Therapeutics, Inc. shareholders
- Schedule 13G · FMR LLC · Jun 5, 2026
- Schedule 13D · SR One Capital Management, LLC · May 18, 2026
- Schedule 13D · Tpg Gp A, LLC · May 18, 2026
- Schedule 13G · Lightspeed Venture Partners XV-B (Ignite), L.P. · May 18, 2026
- Schedule 13D · Jeito II S.L.P. · May 15, 2026